271 related articles for article (PubMed ID: 18054347)
1. Role of P-glycoprotein in accumulation and cytotoxicity of amrubicin and amrubicinol in MDR1 gene-transfected LLC-PK1 cells and human A549 lung adenocarcinoma cells.
Hira A; Watanabe H; Maeda Y; Yokoo K; Sanematsu E; Fujii J; Sasaki J; Hamada A; Saito H
Biochem Pharmacol; 2008 Feb; 75(4):973-80. PubMed ID: 18054347
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of MDR1 in amrubicinol-resistant lung cancer cells.
Takakuwa O; Oguri T; Ozasa H; Uemura T; Kasai D; Miyazaki M; Maeno K; Sato S
Cancer Chemother Pharmacol; 2011 Sep; 68(3):669-76. PubMed ID: 21128075
[TBL] [Abstract][Full Text] [Related]
3. Interaction of imatinib mesilate with human P-glycoprotein.
Hamada A; Miyano H; Watanabe H; Saito H
J Pharmacol Exp Ther; 2003 Nov; 307(2):824-8. PubMed ID: 12975485
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance gene G1199A polymorphism alters efflux transport activity of P-glycoprotein.
Woodahl EL; Yang Z; Bui T; Shen DD; Ho RJ
J Pharmacol Exp Ther; 2004 Sep; 310(3):1199-207. PubMed ID: 15100388
[TBL] [Abstract][Full Text] [Related]
5. Transport of quinolone antibacterial drugs by human P-glycoprotein expressed in a kidney epithelial cell line, LLC-PK1.
Ito T; Yano I; Tanaka K; Inui KI
J Pharmacol Exp Ther; 1997 Aug; 282(2):955-60. PubMed ID: 9262363
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the involvement of P-glycoprotein on the extrusion of taken up L-DOPA in cyclosporine A treated LLC-PK1 cells.
Soares-da-Silva P; Serrão MP; Vieira-Coelho MA; Pestana M
Br J Pharmacol; 1998 Jan; 123(1):13-22. PubMed ID: 9484849
[TBL] [Abstract][Full Text] [Related]
7. Amrubicin induces apoptosis in human tumor cells mediated by the activation of caspase-3/7 preceding a loss of mitochondrial membrane potential.
Hanada M; Noguchi T; Yamaoka T
Cancer Sci; 2006 Dec; 97(12):1396-403. PubMed ID: 16995876
[TBL] [Abstract][Full Text] [Related]
8. Increased cellular accumulation and distribution of amrubicin contribute to its activity in anthracycline-resistant cancer cells.
Mamidipudi V; Shi T; Brady H; Surapaneni S; Chopra R; Aukerman SL; Heise C; Sung V
Cancer Chemother Pharmacol; 2012 Apr; 69(4):965-76. PubMed ID: 22120960
[TBL] [Abstract][Full Text] [Related]
9. Influx and efflux transport as determinants of melphalan cytotoxicity: Resistance to melphalan in MDR1 overexpressing tumor cell lines.
Kühne A; Tzvetkov MV; Hagos Y; Lage H; Burckhardt G; Brockmöller J
Biochem Pharmacol; 2009 Jul; 78(1):45-53. PubMed ID: 19447222
[TBL] [Abstract][Full Text] [Related]
10. Additive effects of amrubicin with cisplatin on human lung cancer cell lines.
Yamauchi S; Kudoh S; Kimura T; Hirata K; Yoshikawa J
Osaka City Med J; 2002 Jun; 48(1):69-76. PubMed ID: 12375699
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of amrubicin, a novel 9-aminoanthracycline, and its active metabolite amrubicinol on human tumor cells.
Yamaoka T; Hanada M; Ichii S; Morisada S; Noguchi T; Yanagi Y
Jpn J Cancer Res; 1998 Oct; 89(10):1067-73. PubMed ID: 9849587
[TBL] [Abstract][Full Text] [Related]
12. Modification of thermosensitivity by amrubicin or amrubicinol in human lung adenocarcinoma A549 cells and the kinetics of apoptosis and necrosis induction.
Hayashi S; Hatashita M; Matsumoto H; Jin ZH; Shioura H; Kano E
Int J Mol Med; 2005 Sep; 16(3):381-7. PubMed ID: 16077943
[TBL] [Abstract][Full Text] [Related]
13. Role of P-glycoprotein in the efflux of raltegravir from human intestinal cells and CD4+ T-cells as an interaction target for anti-HIV agents.
Hashiguchi Y; Hamada A; Shinohara T; Tsuchiya K; Jono H; Saito H
Biochem Biophys Res Commun; 2013 Sep; 439(2):221-7. PubMed ID: 23981805
[TBL] [Abstract][Full Text] [Related]
14. Modulation of cellular cholesterol alters P-glycoprotein activity in multidrug-resistant cells.
Troost J; Lindenmaier H; Haefeli WE; Weiss J
Mol Pharmacol; 2004 Nov; 66(5):1332-9. PubMed ID: 15308763
[TBL] [Abstract][Full Text] [Related]
15. Blonanserin, a novel atypical antipsychotic agent not actively transported as substrate by P-glycoprotein.
Inoue T; Osada K; Tagawa M; Ogawa Y; Haga T; Sogame Y; Hashizume T; Watanabe T; Taguchi A; Katsumata T; Yabuki M; Yamaguchi N
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):156-62. PubMed ID: 22691713
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of radiosensitivity by topoisomerase II inhibitor, amrubicin and amrubicinol, in human lung adenocarcinoma A549 cells and kinetics of apoptosis and necrosis induction.
Hayashi S; Hatashita M; Matsumoto H; Shioura H; Kitai R; Kano E
Int J Mol Med; 2006 Nov; 18(5):909-15. PubMed ID: 17016621
[TBL] [Abstract][Full Text] [Related]
17. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies.
Batrakova EV; Miller DW; Li S; Alakhov VY; Kabanov AV; Elmquist WF
J Pharmacol Exp Ther; 2001 Feb; 296(2):551-7. PubMed ID: 11160643
[TBL] [Abstract][Full Text] [Related]
18. Outward transfer of dopamine precursor L-3,4-dihydroxyphenylalanine (L-dopa) by native and human P-glycoprotein in LLC-PK(1) and LLC-GA5 col300 renal cells.
Soares-Da-Silva P; Serrão MP
J Pharmacol Exp Ther; 2000 May; 293(2):697-704. PubMed ID: 10773046
[TBL] [Abstract][Full Text] [Related]
19. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).
Tanigawara Y; Okamura N; Hirai M; Yasuhara M; Ueda K; Kioka N; Komano T; Hori R
J Pharmacol Exp Ther; 1992 Nov; 263(2):840-5. PubMed ID: 1359120
[TBL] [Abstract][Full Text] [Related]
20. Heterologous expression of various P-glycoproteins in polarized epithelial cells induces directional transport of small (type 1) and bulky (type 2) cationic drugs.
Smit JW; Weert B; Schinkel AH; Meijer DK
J Pharmacol Exp Ther; 1998 Jul; 286(1):321-7. PubMed ID: 9655875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]